Stay updated on Viatris Press Releases
Sign up to get notified when there's something new on the Viatris Press Releases page.

Latest updates to the Viatris Press Releases page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedTwo August 2026 press releases were added to the Viatris Newsroom: Q2 financial results and a quarterly dividend. Several earlier 2026 items were removed, including the May 1 release on data presentations and the April 13 release about the May 7 financial results.SummaryDifference7%

- Check21 days agoChange DetectedA new press release entry for July 29, 2026 announcing FDA approval of Gwyn Lo contraceptive patch was added. The April 10, 2026 data presentations entry was removed from the list.SummaryDifference8%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedNo textual changes were detected in the page changes data. The press releases list appears unchanged.SummaryDifference0.3%

- Check50 days agoChange DetectedTwo new press release items were added to the listing: July 1, 2026 announcing the second-quarter 2026 financial results and June 29, 2026 reporting positive topline results from a Phase 3 study. Additionally, older March 2026 entries were removed from the listing.SummaryDifference7%

- Check93 days agoChange DetectedA new press release dated May 18, 2026 about the FDA accepting Viatris' NDA for fast-acting meloxicam was added, and the February 26, 2026 financial results release was removed from the list.SummaryDifference7%

- Check107 days agoChange DetectedThe Press Releases list has been updated with multiple May 2026 announcements (Bank of America conference, Q1 results, quarterly dividend, CFO transition, and related data presentations). Older items from February and January 2026 have been removed.SummaryDifference8%

Stay in the know with updates to Viatris Press Releases
Enter your email address, and we'll notify you when there's something new on the Viatris Press Releases page.